Entrada Therapeutics | Financial Information

SEC Filings

SEC Filings
Filing date	Form	Description	Filing Group	View
Nov 04, 2021	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001104659-21-134623.pdf 0001104659-21-134623.rtf 0001104659-21-134623.xls
Nov 04, 2021	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001209191-21-063040.pdf 0001209191-21-063040.rtf 0001209191-21-063040.xls
Nov 04, 2021	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001104659-21-134647.pdf 0001104659-21-134647.rtf 0001104659-21-134647.xls
Nov 02, 2021	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001104659-21-132980.pdf 0001104659-21-132980.rtf 0001104659-21-132980.xls
Nov 01, 2021	424B4	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	Registration Statements	View HTML 0001104659-21-132334.pdf 0001104659-21-132334.rtf 0001104659-21-132334.xls